Ubs Group Ag Wave Life Sciences Ltd. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Ubs Group Ag holds 68,802 shares of WVE stock, worth $860,025. This represents 0.0% of its overall portfolio holdings.

Number of Shares

68,802

Previous 119,913 42.62%

Holding current value

$860,025

Previous $598,000 5.69%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.12 - $9.01 $261,688 - $460,510	-51,111 Reduced 42.62%	68,802 $564,000
Q2 2024 Aug 13, 2024	BUY	$4.38 - $6.48 $164,652 - $243,596	37,592 Added 45.67%	119,913 $598,000
Q1 2024 May 13, 2024	BUY	$3.54 - $6.84 $2,608 - $5,041	737 Added 0.9%	82,321 $507,000
Q4 2023 Feb 09, 2024	BUY	$4.16 - $6.87 $235,876 - $389,535	56,701 Added 227.87%	81,584 $411,000
Q3 2023 Nov 09, 2023	BUY	$3.56 - $5.75 $25,635 - $41,405	7,201 Added 40.73%	24,883 $143,000
Q2 2023 Aug 11, 2023	BUY	$3.51 - $4.69 $56,177 - $75,063	16,005 Added 954.38%	17,682 $64,000
Q1 2023 May 12, 2023	SELL	$3.58 - $6.3 $6,494 - $11,428	-1,814 Reduced 51.96%	1,677 $7,000
Q4 2022 Feb 08, 2023	SELL	$3.18 - $7.0 $6,385 - $14,056	-2,008 Reduced 36.52%	3,491 $24,000
Q3 2022 Nov 10, 2022	BUY	$2.37 - $4.28 $5,382 - $9,719	2,271 Added 70.35%	5,499 $20,000
Q2 2022 Aug 10, 2022	SELL	$1.23 - $3.25 $2,865 - $7,572	-2,330 Reduced 41.92%	3,228 $10,000
Q1 2022 May 16, 2022	SELL	$2.0 - $3.28 $35,246 - $57,803	-17,623 Reduced 76.02%	5,558 $11,000
Q4 2021 Feb 14, 2022	BUY	$3.14 - $5.15 $57,797 - $94,796	18,407 Added 385.57%	23,181 $73,000
Q3 2021 Nov 15, 2021	SELL	$4.89 - $7.12 $6,000 - $8,736	-1,227 Reduced 20.45%	4,774 $23,000
Q2 2021 Aug 13, 2021	BUY	$5.65 - $7.47 $6,531 - $8,635	1,156 Added 23.86%	6,001 $40,000
Q1 2021 May 12, 2021	SELL	$5.61 - $12.01 $9,851 - $21,089	-1,756 Reduced 26.6%	4,845 $27,000
Q4 2020 Feb 11, 2021	SELL	$6.99 - $9.26 $13,218 - $17,510	-1,891 Reduced 22.27%	6,601 $52,000
Q3 2020 Nov 12, 2020	BUY	$8.49 - $19.54 $18,644 - $42,909	2,196 Added 34.88%	8,492 $72,000
Q2 2020 Jul 31, 2020	BUY	$7.44 - $11.29 $9,069 - $13,762	1,219 Added 24.01%	6,296 $66,000
Q1 2020 May 01, 2020	BUY	$6.94 - $14.22 $7,474 - $15,314	1,077 Added 26.92%	5,077 $47,000
Q4 2019 Feb 14, 2020	SELL	$7.99 - $37.6 $1,598 - $7,520	-200 Reduced 4.76%	4,000 $32,000
Q3 2019 Nov 14, 2019	SELL	$19.17 - $27.4 $14,530 - $20,769	-758 Reduced 15.29%	4,200 $86,000
Q2 2019 Aug 14, 2019	BUY	$22.93 - $42.84 $17,380 - $32,472	758 Added 18.05%	4,958 $130,000
Q1 2019 May 14, 2019	SELL	$32.69 - $47.91 $182,606 - $267,625	-5,586 Reduced 57.08%	4,200 $163,000
Q4 2018 Feb 14, 2019	BUY	$37.1 - $50.11 $229,500 - $309,980	6,186 Added 171.83%	9,786 $412,000
Q3 2018 Nov 14, 2018	SELL	$36.35 - $55.2 $396,433 - $602,011	-10,906 Reduced 75.18%	3,600 $180,000
Q2 2018 Aug 14, 2018	BUY	$33.85 - $50.65 $208,177 - $311,497	6,150 Added 73.6%	14,506 $554,000
Q1 2018 May 15, 2018	BUY	$32.45 - $54.7 $55,911 - $94,248	1,723 Added 25.98%	8,356 $335,000
Q4 2017 Feb 14, 2018	BUY	$21.8 - $39.35 $70,152 - $126,628	3,218 Added 94.23%	6,633 $233,000
Q3 2017 Nov 14, 2017	BUY	$16.4 - $25.05 $6,805 - $10,395	415 Added 13.83%	3,415 $74,000
Q2 2017 Aug 14, 2017	SELL	N/A	-203 Reduced 6.34%	3,000 $56,000
Q1 2017 Nov 14, 2017	BUY	N/A	3,203	3,203 $89,000

Others Institutions Holding WVE

# of Institutions

164

Shares Held

117M

Call Options Held

148K

Put Options Held

109K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.09B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account